1. Home
  2. AVXL vs CHMI Comparison

AVXL vs CHMI Comparison

Compare AVXL & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$1.26

Market Cap

115.9M

Sector

Health Care

ML Signal

HOLD

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.59

Market Cap

108.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
CHMI
Founded
2004
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
115.9M
108.3M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
AVXL
CHMI
Price
$1.26
$2.59
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $3.10
AVG Volume (30 Days)
★ 1.2M
138.9K
Earning Date
11-24-2026
10-29-2026
Dividend Yield
N/A
★ 15.21%
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$2.17
52 Week High
$7.60
$2.98

Technical Indicators

Market Signals
Indicator
AVXL
CHMI
Relative Strength Index (RSI) 27.79 51.66
Support Level $1.14 $2.55
Resistance Level $1.60 $2.71
Average True Range (ATR) 0.10 0.07
MACD 0.02 0.02
Stochastic Oscillator 14.89 62.96

Price Performance

Historical Comparison
AVXL
CHMI

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: